AU2002256545A1 - Survical promoting ncam binding and ncam ligand biding compounds - Google Patents

Survical promoting ncam binding and ncam ligand biding compounds

Info

Publication number
AU2002256545A1
AU2002256545A1 AU2002256545A AU5654502A AU2002256545A1 AU 2002256545 A1 AU2002256545 A1 AU 2002256545A1 AU 2002256545 A AU2002256545 A AU 2002256545A AU 5654502 A AU5654502 A AU 5654502A AU 2002256545 A1 AU2002256545 A1 AU 2002256545A1
Authority
AU
Australia
Prior art keywords
ncam
survical
promoting
compounds
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002256545A
Inventor
Vladimir Berezin
Elisabeth Bock
Lene Bording Kohler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enkam Pharmaceuticals AS
Original Assignee
Enkam Pharmaceuticals AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enkam Pharmaceuticals AS filed Critical Enkam Pharmaceuticals AS
Publication of AU2002256545A1 publication Critical patent/AU2002256545A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
AU2002256545A 2000-12-12 2001-12-12 Survical promoting ncam binding and ncam ligand biding compounds Abandoned AU2002256545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001863 2000-12-12
DKPA200001863 2000-12-12
PCT/DK2001/000822 WO2002047719A2 (en) 2000-12-12 2001-12-12 Survical promoting ncam binding and ncam ligand biding compounds

Publications (1)

Publication Number Publication Date
AU2002256545A1 true AU2002256545A1 (en) 2002-06-24

Family

ID=8159904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002256545A Abandoned AU2002256545A1 (en) 2000-12-12 2001-12-12 Survical promoting ncam binding and ncam ligand biding compounds

Country Status (5)

Country Link
US (1) US20050069537A1 (en)
EP (1) EP1343517A2 (en)
JP (1) JP2004515534A (en)
AU (1) AU2002256545A1 (en)
WO (1) WO2002047719A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1436318A2 (en) * 2001-09-05 2004-07-14 Enkam Pharmaceuticals A/S Ncam binding compounds
AU2004247026B2 (en) * 2003-05-16 2009-09-24 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of CNS
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
EP1660539B1 (en) * 2003-08-07 2010-06-02 Enkam Pharmaceuticals A/S Compounds comprising lpa
ES2393748T3 (en) 2005-09-26 2012-12-27 Acorda Therapeutics, Inc. Compositions and methods of using ABCI chondroitinase mutants
GB201007428D0 (en) * 2010-04-30 2010-06-16 Imp Innovations Ltd NCAM-VASE and neuroregeneration
ES2673872T3 (en) 2012-06-05 2018-06-26 The Board Of Trustees Of The Leland Stanford Junior University Mimetic of the NCAM peptide for use in the treatment of major depression disorder
RU2656188C1 (en) * 2017-05-03 2018-06-04 Общество с ограниченной ответственностью "Анкрим" (ООО "Анкрим") Synthetic analgesic means of peptide nature and method of its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591432A (en) * 1993-02-17 1997-01-07 Becton, Dickinson And Company Antibody to the neural cell adhesion molecule and methods of use
US5840689A (en) * 1993-10-29 1998-11-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for stimulating the regrowth of neurons
WO1995013291A1 (en) * 1993-11-08 1995-05-18 New York University Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage
US5792743A (en) * 1995-04-19 1998-08-11 Acorda Therapeutics Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
CA2343975A1 (en) * 1998-09-29 2000-04-06 Lars Christian Ronn Ncam binding compounds

Also Published As

Publication number Publication date
WO2002047719A2 (en) 2002-06-20
WO2002047719A3 (en) 2003-02-13
US20050069537A1 (en) 2005-03-31
JP2004515534A (en) 2004-05-27
EP1343517A2 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
AU2002247826A1 (en) Specific binding members
AU2001288301A1 (en) Binding polypeptides and methods based thereon
AU2001275716A1 (en) File analysis
AU2002238052A1 (en) Antibodies that bind both bcma and taci
GB0118662D0 (en) Binding agents
HK1040736B (en) Binding material
GB0111467D0 (en) Book cover and book binding system using the book cover
AU2002245070A1 (en) Novel multidentate sulfur-containing ligands
AU2002236458A1 (en) Texaphyrin coordination compounds and uses thereof
AU2003235857A1 (en) Binder and binding device
AU2001295748A1 (en) Concurrent file access
AU2002256545A1 (en) Survical promoting ncam binding and ncam ligand biding compounds
AU2190801A (en) Binding protein
AU2001261363A1 (en) Methods and compounds for modulating melanocortin receptor ligand binding and activity
AU2001245888A1 (en) Growth factor binding molecules
HK1050660A1 (en) Binding file
AU2001274676A1 (en) Plant-signalling ligand like proteins
AU2002214844A1 (en) Permeable paver
EP1142616A3 (en) Snowboardbinding and a boot for such a binding
AU7427501A (en) Receptor binding molecules
AUPR009500A0 (en) Improved ligand binding assay and associated apparatus
AU2001251181A1 (en) Homeobox binding sites and their uses
AU2002334115A1 (en) Homogeneous ligand binding assay
IL133866A0 (en) Consensus binding structures for ligands
GB0126295D0 (en) Ligand binding domain